Search
Descriptor English: Nimodipine
Descriptor Spanish: Nimodipina
Descriptor nimodipina
Entry term(s) nimodipino
Scope note: Bloqueante de los canales de calcio con actividad cerebrovascular preferencial. Tiene un marcado efecto dilatador cerebrovascular y disminuye la presión sanguínea.
Descriptor Portuguese: Nimodipina
Descriptor French: Nimodipine
Entry term(s): Admon
Bay e 9736
Bayvit, Nimodipino
Brainal
Calnit
Hexal, Nimodipin
Kenesil
Modus
Nimodipin Hexal
Nimodipin ISIS
Nimodipin-ISIS
Nimodipino Bayvit
Nimotop
Nymalize
Remontal
e 9736, Bay
Tree number(s): D03.383.725.203.570
D03.383.725.547.570
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D009553
Scope note: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antihypertensive Agents
Calcium Channel Blockers
Vasodilator Agents
Registry Number: 57WA9QZ5WH
CAS Type 1 Name: 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester
Previous Indexing: Nicotinic Acids (1966-1986)
Public MeSH Note: 87; NIMODIPINE was indexed under NICOTINIC ACIDS 1981-86
History Note: 87; use NIMODIPINE (NM) 1981-86
DeCS ID: 23510
Unique ID: D009553
NLM Classification: QV 150
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1987/01/01
Date of Entry: 1986/06/03
Revision Date: 2017/05/24
Nimodipine - Preferred
Concept UI M0014859
Scope note A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
Preferred term Nimodipine
Bay e 9736 - Narrower
Concept UI M0332201
Preferred term Bay e 9736
Entry term(s) e 9736, Bay
Brainal - Narrower
Concept UI M0463281
Preferred term Brainal
Calnit - Narrower
Concept UI M0463282
Preferred term Calnit
Kenesil - Narrower
Concept UI M0463283
Preferred term Kenesil
Nymalize - Narrower
Concept UI M0584781
Preferred term Nymalize
Nimodipin Hexal - Narrower
Concept UI M0463284
Preferred term Nimodipin Hexal
Entry term(s) Hexal, Nimodipin
Nimodipin-ISIS - Narrower
Concept UI M0463285
Preferred term Nimodipin-ISIS
Entry term(s) Nimodipin ISIS
Nimodipino Bayvit - Narrower
Concept UI M0463286
Preferred term Nimodipino Bayvit
Entry term(s) Bayvit, Nimodipino
Nimotop - Narrower
Concept UI M0014860
Preferred term Nimotop
Remontal - Narrower
Concept UI M0463287
Preferred term Remontal
Admon - Narrower
Concept UI M0463280
Preferred term Admon
Modus - Narrower
Concept UI M0463288
Preferred term Modus



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey